Css LLC Cure Vac N.V. Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$14.73 - $35.25 $156,138 - $373,650	-10,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $20,232 - $28,932	600 Added 6.0%	10,600 $364,000
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $267,477 - $599,391	4,700 Added 88.68%	10,000 $735,000
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $422,887 - $669,337	5,300 New	5,300 $485,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.